![]() |
||||
|
When the high dose (HD) group was divided into HD+ (NAb positive) and HD- (NAb negative) subgroups, they found:9
The authors suggested that the HD+ subgroup's exhibition of a positive relationship between NK cell FA and number of active lesions (similar to the relationship exhibited bythe placebo group) and the HD- subgroup's negative relationship "could suggest that neutralizing antibodies to IFN-b might interfere with the benefits of this cytokine."9 This observation is another interesting example of neutralizing antibodies modifying the action of IFN-b. This article emphasizes that more research into the role of NK cells in multiple sclerosis is required, explaining "[a]lthough the results are consistentwiththe hypothesis that NK cells play a role in the immunopathogenesis of MS, they do not prove a causal relationship. ... If a causal relationship between NK cell FA and disease activity in MS does exist, it would be important to define the mechanisms mediating the effect."9 Studying the effects of various treatments, such as IFN-b, could help researchers understand immune mechanisms that may be relevant in multiple sclerosis. The authors concluded: "Although the role of T cells in MS continues to be a major focus, our studies suggest that NK cells and, in particular, NK cell subsets might also merit additional investigation."9
|
|||
![]() |
||||